A team of researchers at The University of Texas at Austin and the University of Porto have created a new way to target cancer—tin-based nanomaterials combined with near-infrared light. Their work has ...

Immune cells that have been genetically engineered to kill cancerous cells, known as CAR T-cells, have transformed the treatment of blood cancers such as leukaemia, but have proved largely ineffective ...

BERLIN -- Patients with cisplatin-ineligible bladder cancer had huge reductions in clinical events and cancer death when treated with a novel combination therapy before and after surgery, according to ...

Metabolism guides the activation states of regulatory T cells, the immune cells that prevent inappropriate activation of the immune system. St. Jude Children's Research Hospital scientists recently ...

WEARING PINK IN SUPPORT OF BREAST CANCER AWARENESS MONTH. MEMBERS OF THE MANCHESTER PROFESSIONAL FIREFIGHTERS ASSOCIATION, TEAMING UP WITH THE AMERICAN CANCER SOCIETY ON THE SPECIAL DESIGN FOR THEIR ...

Oct 22 (Reuters) - Cancer patients who received mRNA-based COVID vaccines within 100 days of starting treatment with widely used immunotherapies were twice as likely to be alive three years after ...

Researchers will see if treatments focused on blood vessels will extend patients’ lives WEDNESDAY, Oct. 22, 2025 (HealthDay News) — What kills cancer patients is where their malignancy spreads in ...

The DESTINY-Breast11 trial showed in patients with high-risk HER2-positive early breast cancer that the ADC followed by ...